GlassScriptPhysician profile
Jared J Stefanko
NPI 1952567349
$3,468.40
in general payments reported to CMS, 2019-2025
15 companies · $29.26 in 2025
The $29.26 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $12.34 · 2021: $338 · 2022: $2,147 · 2023: $289 · 2024: $254 · 2025: $29.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554 · Entertainment: $18.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.46 |
| Entertainment | $18.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $2,100.00 | 2022 | |
| Depuy Synthes Sales INC. | $425.03 | 2019-2025 | Monovisc |
| Si-Bone, INC. | $281.67 | 2019-2023 | |
| Nevro Corp. | $236.68 | 2022-2024 | Senza |
| Medtronic, INC. | $137.52 | 2021-2025 | Infinity Occipitocervical Upper Thoracic System, Inceptiv, Intellis Adaptivestim |
| Smith+Nephew, INC. | $54.97 | 2019-2021 | |
| Theragen, INC. | $54.21 | 2024 | Actastim-S |
| Globus Medical, INC. | $29.55 | 2023 | Elsa, Elsa Al/Atp |
| Boston Scientific Corporation | $27.93 | 2019-2022 | |
| Providence Medical Technology, INC. | $27.30 | 2024 | |
| Arteriocyte Medical Systems, INC. | $22.50 | 2024 | Magellan |
| Vertex Pharmaceuticals Incorporated | $21.68 | 2024 | |
| Pacira Therapeutics, INC. | $18.52 | 2019 | |
| Argentum Medical | $18.22 | 2024 | |
| Medline Industries LP | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Stefanko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.